ACE and Hypertension: Since one of the primary pathophysiologies of obesity-related hypertension is through activation of the RAAS system, ACE inhibitors or angiotensin receptor blockers (ARBs) may be appropriate as an initial agent for pharmacologic therapy for hypertension in children.